Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone: results of a 24-week double-blind placebo-controlled study.
Year: 2002
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Institution: Amsterdam UMC Location Vrije Universiteit Amsterdam
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W192146159
